
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $57M | -- | -- | $2.70 | -- |
07/29/2025 | Q2 | $56.5M | -- | -- | $2.57 | -- |
04/29/2025 | Q1 | $50.1M | $50.3M | $2.23 | $2.78 | -$0.55 |
02/06/2025 | Q4 | $47.7M | $52.4M | $2.74 | $2.57 | $0.17 |
10/29/2024 | Q3 | -- | $41.8M | $2.11 | $1.77 | $0.34 |
07/29/2024 | Q2 | -- | $39.2M | $1.91 | -- | -- |
04/30/2024 | Q1 | $36.3M | $37.2M | $1.83 | $1.72 | $0.11 |
01/30/2024 | Q4 | $37M | $37.5M | $1.85 | $1.72 | $0.13 |
10/23/2023 | Q3 | -- | -- | $2.01 | $1.56 | $0.45 |
07/24/2023 | Q2 | -- | -- | $1.61 | $1.51 | $0.10 |
04/24/2023 | Q1 | -- | -- | $1.69 | $1.66 | $0.03 |
01/25/2023 | Q4 | -- | -- | $1.54 | $1.27 | $0.27 |
10/31/2022 | Q3 | -- | -- | $1.12 | $1.21 | -$0.09 |
07/25/2022 | Q2 | -- | -- | $1.36 | $1.15 | $0.21 |
04/25/2022 | Q1 | -- | -- | $1.36 | $1.17 | $0.19 |
01/26/2022 | Q4 | -- | -- | $1.42 | $1.34 | $0.08 |
10/27/2021 | Q3 | -- | -- | $1.20 | $1.25 | -$0.05 |
07/28/2021 | Q2 | -- | -- | $2.54 | $1.88 | $0.66 |
04/21/2021 | Q1 | -- | -- | $4.06 | $3.34 | $0.72 |
01/27/2021 | Q4 | -- | -- | $0.98 | $0.77 | $0.21 |
10/29/2020 | Q3 | -- | -- | $0.94 | $0.60 | $0.34 |
07/29/2020 | Q2 | -- | -- | $1.28 | $0.91 | $0.37 |
04/22/2020 | Q1 | -- | -- | $0.21 | $0.39 | -$0.18 |
01/27/2020 | Q4 | -- | -- | $0.53 | $0.58 | -$0.05 |
10/28/2019 | Q3 | -- | -- | $0.52 | $0.60 | -$0.08 |
07/30/2019 | Q2 | -- | -- | $0.59 | $0.54 | $0.05 |
04/29/2019 | Q1 | -- | -- | $0.52 | $0.56 | -$0.04 |
01/28/2019 | Q4 | -- | -- | $0.56 | $0.57 | -$0.01 |
10/29/2018 | Q3 | -- | -- | $0.49 | $0.61 | -$0.12 |
07/30/2018 | Q2 | -- | -- | $0.48 | $0.40 | $0.08 |
04/25/2018 | Q1 | -- | -- | $0.43 | $0.37 | $0.06 |
01/29/2018 | Q4 | -- | -- | $0.36 | -- | -- |
04/25/2017 | Q1 | -- | -- | -- | -- | -- |
01/30/2017 | Q4 | -- | -- | $0.35 | -- | -- |
10/27/2016 | Q3 | -- | -- | $0.19 | -- | -- |
07/27/2016 | Q2 | -- | -- | $0.24 | -- | -- |
05/02/2016 | Q1 | -- | -- | $0.19 | -- | -- |
02/02/2016 | Q4 | -- | -- | $0.18 | -- | -- |
10/26/2015 | Q3 | -- | -- | $0.20 | -- | -- |
Northeast Bank reported $50.3M worth of top line sales in its most recent quarter.
Northeast Bank announced earnings per share of $2.23 which represents a miss of analyst forecast a $2.78 per share.
Northeast Bank reported -- that represents -- per share over the last quarter.
Northeast Bank's earnings are forecast to grow from $7.58 per share to $10.74 per share next year representing an increase of 41.62%.
Northeast Bank's next earnings date is July 29, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.